Risk Factors of Tuberculosis Destroyed Lung in Patients with Pulmonary Tuberculosis and Structural Lung Diseases: A Retrospective Observational Study

References

• Igbokwe V, Ruby LC, Sultanli A, Bélard S. Post-tuberculosis sequelae in children and adolescents: a systematic review. Lancet Infect Dis. 2023;23(4):e138–e150. doi:10.1016/S1473-3099(23)00004-X
   PubMedGoogle Scholar
• Dodd PJ, Yuen CM, Jayasooriya SM, van der Zalm MM, Seddon JA. Quantifying the global number of tuberculosis survivors: a modelling study. Lancet Infect Dis. 2021;21(7):984–992. doi:10.1016/S1473-3099(20)30919-1
   PubMedGoogle Scholar
• Menzies NA, Quaife M, Allwood BW, et al. Lifetime burden of disease due to incident tuberculosis: a global reappraisal including post-tuberculosis sequelae. Lancet Glob Health. 2021;9(12):e1679–e1687. doi:10.1016/S2214-109X(21)00367-3
   PubMedGoogle Scholar
• Meghji J, Simpson H, Squire SB, Mortimer K, Hill PC. A systematic review of the prevalence and pattern of imaging defined post-TB lung disease. PLoS One. 2016;11(8):e0161176. doi:10.1371/journal.pone.0161176
   PubMedGoogle Scholar
• Allwood BW, Myer L, Bateman ED. A systematic review of the association between pulmonary tuberculosis and the development of chronic airflow obstruction in adults. Respiration. 2013;86(1):76–85. doi:10.1159/000350917
   PubMed Web of Science ®Google Scholar
• Lam K, Bong H, Jiang CQ, et al. Prior TB, smoking, and airflow obstruction: a cross-sectional analysis of the Guangzhou Biobank Cohort Study. Chest. 2010;137(3):593–600. doi:10.1378/chest.09-1435
   PubMed Web of Science ®Google Scholar
• Ehrlich RI, Adams S, Baatjies R, Jeebhay MF. Chronic airflow obstruction and respiratory symptoms following tuberculosis: a review of South African studies. Int J Tuberc Lung Dis. 2011;15(7):886–891. doi:10.5588/ijtld.10.0526
   PubMed Web of Science ®Google Scholar
• Osman M, Welte A, Dunbar R, et al. Morbidity and mortality up to 5 years post tuberculosis treatment in South Africa: a pilot study. Int J Infect Dis. 2019;85:57–63. doi:10.1016/j.ijid.2019.05.024
   PubMed Web of Science ®Google Scholar
• Nightingale R, Chinoko B, Lesosky M, et al. Respiratory symptoms and lung function in patients treated for pulmonary tuberculosis in Malawi: a prospective cohort study. Thorax. 2022;77(11):1131–1139. doi:10.1136/thoraxjnl-2021-217190
   PubMedGoogle Scholar
• Lin Y, Liu Y, Zhang G, et al. Is it feasible to conduct post-tuberculosis assessments at the end of tuberculosis treatment under routine programmatic conditions in China? Trop Med Infect Dis. 2021;6(3):164. doi:10.3390/tropicalmed6030164
   PubMedGoogle Scholar
• Ravimohan S, Kornfeld H, Weissman D, Bisson GP. Tuberculosis and lung damage: from epidemiology to pathophysiology. Eur Respir Rev. 2018;27(147):170077. doi:10.1183/16000617.0077-2017
   PubMed Web of Science ®Google Scholar
• Sarkar M, Srinivasa, Madabhavi I, Kumar K. Tuberculosis associated chronic obstructive pulmonary disease. Clin Respir J. 2017;11(3):285–295. doi:10.1111/crj.12621
   PubMed Web of Science ®Google Scholar
• Allwood BW, Byrne A, Meghji J, Rachow A, van der Zalm MM, Schoch OD. Post-tuberculosis lung disease: clinical review of an under-recognised global challenge. Respiration. 2021;100(8):751–763. doi:10.1159/000512531
   PubMed Web of Science ®Google Scholar
• Malherbe ST, Dupont P, Kant I, et al. A semi-automatic technique to quantify complex tuberculous lung lesions on 18F-fluorodeoxyglucose positron emission tomography/computerised tomography images. EJNMMI Res. 2018;8(1):55. doi:10.1186/s13550-018-0411-7
   PubMedGoogle Scholar
• Stek C, Allwood B, Walker NF, Wilkinson RJ, Lynen L, Meintjes G. The immune mechanisms of lung parenchymal damage in tuberculosis and the role of host-directed therapy. Front Microbiol. 2018;9:2603. doi:10.3389/fmicb.2018.02603
   PubMedGoogle Scholar
• Urbanowski ME, Ordonez AA, Ruiz-Bedoya CA, Jain SK, Bishai WR. Cavitary tuberculosis: the gateway of disease transmission. Lancet Infect Dis. 2020;20(6):e117–e128. doi:10.1016/S1473-3099(20)30148-1
   PubMed Web of Science ®Google Scholar
• Dorhoi A, Kaufmann SHE. Pathology and immune reactivity: understanding multidimensionality in pulmonary tuberculosis. Semin Immunopathol. 2016;38(2):153–166. doi:10.1007/s00281-015-0531-3
   PubMed Web of Science ®Google Scholar
• Han D, Lee HY, Kim K, Kim T, Oh YM, Rhee CK. Burden and clinical characteristics of high grade tuberculosis destroyed lung: a nationwide study. J Thorac Dis. 2019;11(10):4224–4233. doi:10.21037/jtd.2019.09.63
   PubMedGoogle Scholar
• Bongomin F, Chowdhary A. Post-tuberculosis chronic pulmonary aspergillosis: an emerging public health concern. PLoS Pathog. 2020;16(8):e1008742. doi:10.1371/journal.ppat.1008742
   PubMedGoogle Scholar
• Kosif Mısırlıoğlu A, Bayram S, Kıral H, et al. Factors affecting complication rates of pneumonectomy in destroyed lung. Turk Gogus Kalp Damar Cerrahisi Derg. 2018;26(2):272–278. doi:10.5606/tgkdc.dergisi.2018.14635
   PubMedGoogle Scholar
• Lee JH, Chang JH. Lung function in patients with chronic airflow obstruction due to tuberculous destroyed lung. Respir Med. 2003;97(11):1237–1242. doi:10.1016/s0954-6111(03)00255-5
   PubMedGoogle Scholar
• Rhee CK, Yoo KH, Lee JH, et al. Clinical characteristics of patients with tuberculosis-destroyed lung. Int J Tuberc Lung Dis. 2013;17(1):67–75. doi:10.5588/ijtld.12.0351
   PubMed Web of Science ®Google Scholar
• Kim CJ, Yoon HK, Park MJ, et al. Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study. Int J Chron Obstruct Pulmon Dis. 2017;12:1589–1596. doi:10.2147/COPD.S128750
   PubMed Web of Science ®Google Scholar
• Kim SJ, Lee J, Park YS, et al. Effect of airflow limitation on acute exacerbations in patients with destroyed lungs by tuberculosis. J Korean Med Sci. 2015;30(6):737–742. doi:10.3346/jkms.2015.30.6.737
   PubMedGoogle Scholar
• Jo YS, Park JH, Lee JK, Heo EY, Chung HS, Kim DK. Risk factors for pulmonary arterial hypertension in patients with tuberculosis-destroyed lungs and their clinical characteristics compared with patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2017;12:2433–2443. doi:10.2147/COPD.S136304
   PubMed Web of Science ®Google Scholar
• Blyth DF. Pneumonectomy for inflammatory lung disease. Eur J Cardiothorac Surg. 2000;18(4):429–434. doi:10.1016/s1010-7940(00)00526-1
   PubMed Web of Science ®Google Scholar
• Shiraishi Y, Nakajima Y, Koyama A, Takasuna K, Katsuragi N, Yoshida S. Morbidity and mortality after 94 extrapleural pneumonectomies for empyema. Ann Thorac Surg. 2000;70(4):1202–1206; discussion 1206–1207. doi:10.1016/s0003-4975(00)01612-x
   Google Scholar
• Ruan H, Liu F, Han M, Gong C. Incidence and risk factors of postoperative complications in patients with tuberculosis-destroyed lung. BMC Pulm Med. 2021;21(1):273. doi:10.1186/s12890-021-01641-0
   PubMedGoogle Scholar
• Wang X, Luo L, Zhang D, et al. Factors associated with nutritional risk in patients with pulmonary tuberculosis and structural lung disease: a hospital-based cross-sectional study. J Multidiscip Healthc. 2022;15:1799–1807. doi:10.2147/JMDH.S375441
   PubMed Web of Science ®Google Scholar
• Ryu YJ, Lee JH, Chun EM, Chang JH, Shim SS. Clinical outcomes and prognostic factors in patients with tuberculous destroyed lung. Int J Tuberc Lung Dis. 2011;15(2):246–250.
   PubMedGoogle Scholar
• Fawibe AE, Salami AK, Oluboyo PO, Desalu OO, Odeigha LO. Profile and outcome of unilateral tuberculous lung destruction in Ilorin, Nigeria. West Afr J Med. 2011;30(2):130–135.
   PubMedGoogle Scholar
• Ruan H, Gong C, Wang J. The efficacy and safety of surgical treatment for patients with tuberculosis destroyed lung with or without chronic pulmonary aspergillosis. World J Surg. 2021;45(5):1595–1601. doi:10.1007/s00268-021-05969-w
   PubMedGoogle Scholar
• Middelkoop K, Bekker LG, Shashkina E, Kreiswirth B, Wood R. Retreatment tuberculosis in a South African community: the role of re-infection, HIV and antiretroviral treatment. Int J Tuberc Lung Dis. 2012;16(11):1510–1516. doi:10.5588/ijtld.12.0049
   PubMed Web of Science ®Google Scholar
• Cohen DB, Davies G, Malwafu W, et al. Poor outcomes in recurrent tuberculosis: more than just drug resistance? PLoS One. 2019;14(5):e0215855. doi:10.1371/journal.pone.0215855
   PubMed Web of Science ®Google Scholar
• Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax. 2000;55(1):32–38. doi:10.1136/thorax.55.1.32
   PubMed Web of Science ®Google Scholar
• Peltzer K, Louw J. Prevalence of suicidal behaviour & associated factors among tuberculosis patients in public primary care in South Africa. Indian J Med Res. 2013;138(2):194–200.
   PubMed Web of Science ®Google Scholar
• de Araújo GS, Pereira SM, Dos Santos DN, Marinho JM, Rodrigues LC, Barreto ML. Common mental disorders associated with tuberculosis: a matched case-control study. PLoS One. 2014;9(6):e99551. doi:10.1371/journal.pone.0099551
   PubMed Web of Science ®Google Scholar
• Ockenga J, Fuhse K, Chatterjee S, et al. Tuberculosis and malnutrition: the European perspective. Clin Nutr. 2023;42(4):486–492. doi:10.1016/j.clnu.2023.01.016
   PubMed Web of Science ®Google Scholar
• Putri FA, Burhan E, Nawas A, et al. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia. Int j Tuberc Lung Dis. 2014;18(5):564–570. doi:10.5588/ijtld.13.0602
   PubMed Web of Science ®Google Scholar
• Birlie A, Tesfaw G, Dejene T, Woldemichael K, Hill PC. Time to death and associated factors among tuberculosis patients in Dangila Woreda, Northwest Ethiopia. PLoS One. 2015;10(12):e0144244. doi:10.1371/journal.pone.0144244
   PubMed Web of Science ®Google Scholar
• Hoyt KJ, Sarkar S, White L, et al. Effect of malnutrition on radiographic findings and mycobacterial burden in pulmonary tuberculosis. PLoS One. 2019;14(3):e0214011. doi:10.1371/journal.pone.0214011
   PubMed Web of Science ®Google Scholar
• Sinha P, Ponnuraja C, Gupte N, et al. Impact of undernutrition on tuberculosis treatment outcomes in India: a multicenter, prospective, cohort analysis. Clinl Infect Dis. 2023;76(8):1483–1491. doi:10.1093/cid/ciac915
   PubMedGoogle Scholar
• Badawi A, Gregg B, Vasileva D. Systematic analysis for the relationship between obesity and tuberculosis. Public Health. 2020;186:246–256. doi:10.1016/j.puhe.2020.06.054
   PubMedGoogle Scholar
• Abdullah A, Peeters A, de Courten M, Stoelwinder J. The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies. Diabet Res Clin Pract. 2010;89(3):309–319. doi:10.1016/j.diabres.2010.04.012
   PubMed Web of Science ®Google Scholar